Mamiko Takayasu
Overview
Explore the profile of Mamiko Takayasu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimohata H, Usui J, Tawara-Iida T, Ebihara I, Ishizu T, Maeda Y, et al.
Clin Exp Nephrol
. 2024 Jan;
28(5):457-464.
PMID: 38238500
Background: Patients with end-stage kidney disease (ESKD) are at high risk of cardiovascular disease including stroke, heart failure, and ischemic heart disease (IHD). To prevent the occurrence and progression of...
2.
Yamashita M, Takayasu M, Maruyama H, Hirayama K
Medicina (Kaunas)
. 2023 Nov;
59(11).
PMID: 38004064
Combination therapy with glucocorticoids, cyclophosphamide, and plasmapheresis is recommended as the standard treatment for anti-glomerular basement membrane (anti-GBM) disease, but the prognosis of this disease remains poor. Several immunobiological agents...
3.
Takayasu M, Hirayama K, Shimohata H, Kobayashi M, Koyama A
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806487
Since 1995, when we reported the case of a patient with glomerulonephritis with IgA deposition that occurred after a methicillin-resistant (MRSA) infection, many reports of MRSA infection-associated glomerulonephritis have accumulated....
4.
Shimohata H, Iwaki Y, Yamashita M, Ohgi K, Maruyama H, Takayasu M, et al.
Int Urol Nephrol
. 2021 Nov;
54(8):1907-1914.
PMID: 34843041
Purpose: The sodium-glucose cotransporter 2 (SGLT2) inhibitors comprise a new class of glucose-lowering drugs for individuals with diabetes. Large-scale clinical trials indicated that SGLT2 inhibitors have both a cardiovascular-protective and...
5.
Usui J, Kawashima S, Sada K, Miyawaki Y, Nakazawa D, Itabashi M, et al.
Clin Exp Nephrol
. 2021 Sep;
25(12):1286-1291.
PMID: 34564791
No abstract available.
6.
Maruyama H, Hirayama K, Yamashita M, Ohgi K, Tsujimoto R, Takayasu M, et al.
BMC Rheumatol
. 2020 Sep;
4:36.
PMID: 32864569
Background: Proteasomes are found in both the cell nucleus and cytoplasm and play a major role in the ubiquitin-dependent and -independent non-lysosomal pathways of intracellular protein degradation. Proteasomes are also...
7.
Shimohata H, Imagawa K, Yamashita M, Ohgi K, Maruyama H, Takayasu M, et al.
Intern Med
. 2020 Jul;
59(22):2907-2910.
PMID: 32727995
Alagille syndrome is an inherited multisystemic disorder. We herein report an atypical case of a Japanese adult patient with Alagille syndrome. He had been diagnosed with Alagille syndrome as an...
8.
Shimohata H, Yamashita M, Ohgi K, Maruyama H, Takayasu M, Hirayama K, et al.
CEN Case Rep
. 2020 Mar;
9(3):237-242.
PMID: 32189245
Fabry disease is an X-linked inherited lysosomal storage disorder caused by a deficiency of α-galactosidase A activity, resulting in the intracellular accumulation of globotriaosylceramide and related glycosphingolipids. The phenotypes of...
9.
Shimohata H, Yamashita M, Ohgi K, Tsujimoto R, Maruyama H, Takayasu M, et al.
Hemodial Int
. 2019 May;
23(3):369-374.
PMID: 31037843
Introduction Recently, although there are many reports showing that serum magnesium concentration is a predictor of mortality in dialysis patients, the observation periods of those reports were of short duration,...
10.
Miyamoto Y, Hirayama K, Maruyama H, Ohgi K, Takayasu M, Shimohata H, et al.
BMC Nephrol
. 2019 Apr;
20(1):123.
PMID: 30961527
Background: Thymic hyperplasia and thymic epithelial tumor (thymoma) have been associated with a variety of autoimmune diseases. Renal involvement has been reported in patients with thymoma. Minimal change disease and...